Sepsis, a 2020 review for the internist

1. SINGER M., DEUTSCHMAN CS., SEYMOUR C.W., SHANKAR-HARI M., ANNANE D., BAUER M., BELLOMO R., BERNARD GR., CHICHE JD., COOPERSMITH C.M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 2016; 315(8):801–810.10.1001/jama.2016.0287496857426903338Search in Google Scholar

2. FLEISCHMANN C., SCHERAG A., ADHIKARI NK, HARTOG CS., TSAGANOS T., SCHLATTMANN P., ANGUS DC., REINHART K. Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. Am J Respir Crit Care Med 2016; 193(3):259–272.10.1164/rccm.201504-0781OC26414292Search in Google Scholar

3. DELLINGER RP., CARLET JM., MASUR H., GERLACH H., CALANDRA T., COHEN J., GEA-BANACLOCHE J., KEH D., MARSHALL JC., PARKER MM. et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32(3):858–873.10.1097/01.CCM.0000117317.18092.E415090974Search in Google Scholar

4. AMERICAN COLLEGE OF CHEST PHYSICIANS/SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20(6):864–874.10.1097/00003246-199206000-00025Search in Google Scholar

5. PRO CI., YEALY DM., KELLUM JA., HUANG DT., BARNATO AE., WEISSFELD LA., PIKE F., TERNDRUP T., WANG HE., HOU PC. et al. A randomized trial of protocol-based care for early septic shock. The New England journal of medicine 2014; 370(18):1683–1693.10.1056/NEJMoa1401602410170024635773Search in Google Scholar

6. MOUNCEY PR., OSBORN TM., POWER GS., HARRISON DA., SADIQUE MZ., GRIEVE RD., JAHAN R., HARVEY SE., BELL D., BION JF. et al: Trial of early, goal-directed resuscitation for septic shock. The New England journal of medicine 2015; 372(14):1301–1311.10.1056/NEJMoa150089625776532Search in Google Scholar

7. PEAKE SL., DELANEY A., BAILEY M., BELLOMO R., CAMERON PA., COOPER DJ., HIGGINS AM., HOLDGATE A. et al. Goal-directed resuscitation for patients with early septic shock. The New England journal of medicine. 2014; 371(16):1496–1506.10.1056/NEJMoa140438025272316Search in Google Scholar

8. CHURPEK MM., ZADRAVECZ FJ., WINSLOW C., HOWELL MD., EDELSON DP. Incidence and Prognostic Value of the Systemic Inflammatory Response Syndrome and Organ Dysfunctions in Ward Patients. Am J Respir Crit Care Med. 2015; 192(8):958–964.10.1164/rccm.201502-0275OC464220926158402Search in Google Scholar

9. SEYMOUR CW., KENNEDY JN., WANG S., CHANG CH., ELLIOTT CF., XU Z., BERRY S., CLERMONT G., COOPER G., GOMEZ H. et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019; 321(20):2003–2017.10.1001/jama.2019.5791653781831104070Search in Google Scholar

10. KUMAR A., ROBERTS D., WOOD KE., LIGHT B., PARRILLO JE., SHARMA S., SUPPES R., FEINSTEIN D., ZANOTTI S., TAIBERG L. et al: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596.10.1097/01.CCM.0000217961.75225.E916625125Search in Google Scholar

11. KOVACH CP., FLETCHER GS., RUDD KE., GRANT RM., CARLBOM DJ. Comparative prognostic accuracy of sepsis scores for hospital mortality in adults with suspected infection in non-ICU and ICU at an academic public hospital. PloS one 2019, 14(9):e0222563.10.1371/journal.pone.0222563674650031525224Search in Google Scholar

12. ANAND V., ZHANG Z., KADRI SS., KLOMPAS M., RHEE C., PROGRAM CDCPE: Epidemiology of Quick Sequential Organ Failure Assessment Criteria in Undifferentiated Patients and Association With Suspected Infection and Sepsis. Chest 2019; 156(2):289–297.10.1016/j.chest.2019.03.032685924530978329Search in Google Scholar

13. THWAITES CL., LUNDEG G., DONDORP AM. Sepsis in resource-limited settings-expert consensus recommendations group of the European Society of Intensive Care M, the Mahidol-Oxford Research Unit in Bangkok T: Recommendations for infection management in patients with sepsis and septic shock in resource-limited settings. Intensive care medicine 2016; 42(12):2040–2042.10.1007/s00134-016-4415-3510649327324344Search in Google Scholar

14. BONE RC., BALK RA., CERRA FB., DELLINGER RP., FEIN AM., KNAUS WA., SCHEIN RM., SIBBALD WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101(6):1644–1655.Search in Google Scholar

15. SEYMOUR CW., LIU VX., IWASHYNA TJ., BRUNKHORST FM., REA TD., SCHERAG A., RUBENFELD G., KAHN JM., SHANKAR-HARI M., SINGER M et al. Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315(8):762–774.10.1001/jama.2016.0288543343526903335Search in Google Scholar

16. SMITH GB., PRYTHERCH DR., MEREDITH P., SCHMIDT PE., FEATHERSTONE PI. The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation 2013; 84(4):465–470.10.1016/j.resuscitation.2012.12.01623295778Search in Google Scholar

17. LIU VX., FIELDING-SINGH V., GREENE JD., BAKER JM., IWASHYNA TJ., BHATTACHARYA J., ESCOBAR GJ. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am J Respir Crit Care Med. 2017; 196(7):856–863.10.1164/rccm.201609-1848OC564997328345952Search in Google Scholar

18. LEVY MM., EVANS LE., RHODES A. The Surviving Sepsis Campaign Bundle: 2018 Update. Crit Care Med 2018; 46(6):997–1000.10.1097/CCM.000000000000311929767636Search in Google Scholar

19. STERLING SA., MILLER WR., PRYOR J., PUSKARICH MA., JONES AE. The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Crit Care Med. 2015; 43(9):1907–1915.10.1097/CCM.0000000000001142459731426121073Search in Google Scholar

20. FILBIN MR., THORSEN JE., ZACHARY TM., LYNCH JC., MATSUSHIMA M., BELSKY JB., HELDT T., REISNER AT. Antibiotic Delays and Feasibility of a 1-Hour-From-Triage Antibiotic Requirement: Analysis of an Emergency Department Sepsis Quality Improvement Database. Annals of emergency medicine. 2020; 75(1):93–99.10.1016/j.annemergmed.2019.07.01731561998Search in Google Scholar

21. CHENG MP., STENSTROM R., PAQUETTE K., STABLER SN., AKHTER M., DAVIDSON AC., GAVRIC M., LAWANDI A., JINAH R., SAEED Z. et al. Blood Culture Results Before and After Antimicrobial Administration in Patients With Severe Manifestations of Sepsis: A Diagnostic Study. Ann Intern Med. 2019; 171(8):547–554.10.7326/M19-169631525774Search in Google Scholar

22. BOUZA E., SOUSA D., RODRIGUEZ-CREIXEMS M., LECHUZ JG., MUNOZ P. Is the volume of blood cultured still a significant factor in the diagnosis of bloodstream infections? Journal of clinical microbiology 2007; 45(9):2765–2769.Search in Google Scholar

23. KEE PP., CHINNAPPAN M., NAIR A., YEAK D., CHEN A., STARR M., DALEY AJ., CHENG AC., BURGNER D. Diagnostic Yield of Timing Blood Culture Collection Relative to Fever. The Pediatric infectious disease journal. 2016; 35(8):846–850.10.1097/INF.000000000000118927164461Search in Google Scholar

24. LEE A., MIRRETT S., RELLER LB., WEINSTEIN MP. Detection of bloodstream infections in adults: how many blood cultures are needed? Journal of clinical microbiology. 2007; 45(11):3546–3548.10.1128/JCM.01555-07216849717881544Search in Google Scholar

25. PITTET D., MENICHETTI F., ANTUNES F., GARAU J., GRANINGER W., GRUNEBERG RN., PEETERMANS WE., SHAH PM. Empirical antibacterial treatment for sepsis and the role of glycopeptides: recommendations from a European panel. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 1997; 3(3):273–282.10.1111/j.1469-0691.1997.tb00614.x11864121Search in Google Scholar

26. METLAY JP., WATERER GW., LONG AC., ANZUETO A., BROZEK J., CROTHERS K., COOLEY LA., DEAN NC., FINE MJ., FLANDERS SA. et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019; 200(7):e45–e67.10.1164/rccm.201908-1581ST681243731573350Search in Google Scholar

27. SARTELLI M., CATENA F., ABU-ZIDAN FM., ANSALONI L., BIFFL WL., BOERMEESTER MA., CERESOLI M., CHIARA O., COCCOLINI F., DE WAELE JJ. et al. Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg. 2017; 12:22.10.1186/s13017-017-0132-7541873128484510Search in Google Scholar

28. PAUL M., LADOR A., GROZINSKY-GLASBERG S., LEIBOVICI L. Beta lactam antibiotic monotherapy versus beta lactamaminoglycoside antibiotic combination therapy for sepsis. The Cochrane database of systematic reviews 2014; 1:CD003344.10.1002/14651858.CD003344.pub3651712824395715Search in Google Scholar

29. PUGH R., GRANT C., COOKE RP., DEMPSEY G. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults. The Cochrane database of systematic reviews 2015; 8:CD007577.10.1002/14651858.CD007577.pub3702579826301604Search in Google Scholar

30. KWON JW., KIM YJ., YANG MS., SONG WJ., KIM SH., CHO SH., CHANG YS. Results of Intradermal Skin Testing with Cefazolin according to a History of Hypersensitivity to Antibiotics. Journal of Korean medical science. 2019; 34(50):e319.10.3346/jkms.2019.34.e319693555831880416Search in Google Scholar

31. CASTELLS M., KHAN DA., PHILLIPS EJ. Penicillin Allergy. The New England journal of medicine 2019; 381(24):2338–2351.10.1056/NEJMra180776131826341Search in Google Scholar

32. SEMLER MW., SELF WH., WANDERER JP., EHRENFELD JM., WANG L., BYRNE DW., STOLLINGS JL., KUMAR AB., HUGHES CG., HERNANDEZ A. et al. Balanced Crystalloids versus Saline in Critically Ill Adults. The New England journal of medicine 2018; 378(9):829–839.10.1056/NEJMoa1711584584608529485925Search in Google Scholar

33. CORL KA., PRODROMOU M., MERCHANT RC., GAREEN I., MARKS S., BANERJEE D., AMASS T., ABBASI A., DELCOMPARE C., PALMISCIANO A. et al. The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study. Crit Care Med. 2019; 47(7):951–959.10.1097/CCM.0000000000003779657968330985449Search in Google Scholar

34. LIU V., MOREHOUSE JW., SOULE J., WHIPPY A., ESCOBAR GJ. Fluid volume, lactate values, and mortality in sepsis patients with intermediate lactate values. Annals of the American Thoracic Society. 2013; 10(5):466–473.10.1513/AnnalsATS.201304-099OC547542024004068Search in Google Scholar

35. PURCAREA A., BOURGARIT A., SOVAILA S., GHIURA C., DIEMUNSCH P., ANDRES E. Brief report: Serial capillary lactate measurement predict the evolution of early sepsis. J Med Life. 2016; 9(1):74–78.Search in Google Scholar

36. THEERAWIT P., NA PETVICHARN C., TANGSUJARITVIJIT V., SUTHERASAN Y. The Correlation Between Arterial Lactate and Venous Lactate in Patients With Sepsis and Septic Shock. J Intensive Care Med. 2018; 33(2):116–120.10.1177/088506661666316927502951Search in Google Scholar

37. MONNET X., MARIK P., TEBOUL JL. Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis. Intensive care med. 2016; 42(12):1935–1947.10.1007/s00134-015-4134-126825952Search in Google Scholar

38. LARA B., ENBERG L., ORTEGA M., LEON P., KRIPPER C., AGUILERA P., KATTAN E., CASTRO R., BAKKER J., HERNANDEZ G. Capillary refill time during fluid resuscitation in patients with sepsis-related hyperlactatemia at the emergency department is related to mortality. PloS one. 2017; 12(11):e0188548.10.1371/journal.pone.0188548570352429176794Search in Google Scholar

39. LEACH R. Fluid management on hospital medical wards. Clinical medicine. 2010; 10(6):611–615.10.7861/clinmedicine.10-6-611495187221413489Search in Google Scholar

40. STERN A., SKALSKY K., AVNI T., CARRARA E., LEIBOVICI L., PAUL M. Corticosteroids for pneumonia. The Cochrane database of systematic reviews 2017; 12:CD007720.10.1002/14651858.CD007720.pub3648621029236286Search in Google Scholar

41. SOLOMON M., BARZILAI A., ELPHASY H., TRAU H., BAUM S. Corticosteroid Therapy in Combination with Antibiotics for Erysipelas. IMAJ 2018; 20(3):137–140.Search in Google Scholar

42. MARIK PE., KHANGOORA V., RIVERA R., HOOPER MH., CATRAVAS J. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest 2017; 151(6):1229–1238.10.1016/j.chest.2016.11.03627940189Search in Google Scholar

43. SHIN TG., KIM YJ., RYOO SM., HWANG SY., JO IJ., CHUNG SP., CHOI SH., SUH GJ., KIM WY. Early Vitamin C and Thiamine Administration to Patients with Septic Shock in Emergency Departments: Propensity Score-Based Analysis of a Before-and-After Cohort Study. Journal of clinical medicine 2019; 8(1). 9 Sepsis, a 2020 review for the internist 13710.3390/jcm8010102635224630654592Search in Google Scholar

44. LITWAK JJ., CHO N., NGUYEN HB., MOUSSAVI K., BUSHELL T. Vitamin C, Hydrocortisone, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Analysis of Real-World Application. Journal of clinical medicine 2019; 8(4).10.3390/jcm8040478651800330970560Search in Google Scholar

45. HAGER DN., HOOPER MH., BERNARD GR., BUSSE LW., ELY EW., FOWLER AA., GAIESKI DF., HALL A., HINSON JS., JACKSON JC. et al. The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial. Trials 2019; 20(1):197.10.1186/s13063-019-3254-2645123130953543Search in Google Scholar

46. FOWLER AA., TRUWIT JD., HITE RD., MORRIS PE., DEWILDE C., PRIDAY A., FISHER B., THACKER LR., NATARAJAN R., BROPHY DF. et al. Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019; 322(13):1261–1270.10.1001/jama.2019.11825677726831573637Search in Google Scholar

47. FUJII T., LUETHI N., YOUNG PJ., FREI DR., EASTWOOD GM., FRENCH CJ., DEANE AM., SHEHABI Y., HAJJAR LA., OLIVEIRA G. et al. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial. JAMA. 2020; 323(5):423–431.10.1001/jama.2019.22176702976131950979Search in Google Scholar

48. HEMILA H., CHALKER E. Vitamin C for preventing and treating the common cold. The Cochrane database of systematic reviews. 2013; 1:CD000980.10.1002/14651858.CD000980.pub4807815223440782Search in Google Scholar

49. DONNINO MW., ANDERSEN LW., CHASE M., BERG KM., TIDSWELL M., GIBERSON T., WOLFE R., MOSKOWITZ A., SMITHLINE H., NGO L. et al. Randomized, Double-Blind, Placebo-Controlled Trial of Thiamine as a Metabolic Resuscitator in Septic Shock: A Pilot Study. Crit Care Med. 2016; 44(2):360–367.10.1097/CCM.0000000000001572475467026771781Search in Google Scholar

50. ANNANE D., BELLISSANT E., BOLLAERT PE., BRIEGEL J., KEH D., KUPFER Y., PIRRACCHIO R., ROCHWERG B. Corticosteroids for treating sepsis in children and adults. The Cochrane database of systematic reviews. 2019; 12:CD002243.10.1002/14651858.CD002243.pub4695340331808551Search in Google Scholar